{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:04:04Z","timestamp":1761919444877,"version":"build-2065373602"},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.cjca.2010.12.020","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T19:51:46Z","timestamp":1301687506000},"page":"183-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk"],"prefix":"10.1016","volume":"27","author":[{"given":"Samantha","family":"Warnakula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khosrow","family":"Adeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Mahmood","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Tso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer D.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"WHO, Cardiovascular diseases (CVDs), Fact sheet N\u00b0317, January 2011.","key":"10.1016\/j.cjca.2010.12.020_bib1"},{"key":"10.1016\/j.cjca.2010.12.020_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/41.1.153","article-title":"Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins","volume":"41","author":"Zilversmit","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0300-2977(99)00127-8","article-title":"Triglycerides and atherosclerosis: To feast or fast","volume":"56","author":"Cabezas","year":"2000","journal-title":"Neth J Med"},{"key":"10.1016\/j.cjca.2010.12.020_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00041433-200210000-00001","article-title":"Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis","volume":"13","author":"Proctor","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"suppl A","key":"10.1016\/j.cjca.2010.12.020_bib5","first-page":"26A","article-title":"Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis","volume":"10","author":"Huff","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2010.12.020_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0021-9150(94)90085-X","article-title":"Postprandial lipoproteins and progression of coronary atherosclerosis","volume":"106","author":"Karpe","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.020_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11883-005-0037-x","article-title":"Remnant lipoproteins and atherosclerosis","volume":"7","author":"Twickler","year":"2005","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cjca.2010.12.020_bib8","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.0000084638.14534.0A","article-title":"Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of watanabe heritable hyperlipidemic rabbits","volume":"23","author":"Proctor","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2010.12.020_bib9","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/01.ATV.0000143859.75035.5a","article-title":"Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy","volume":"24","author":"Proctor","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2010.12.020_bib10","doi-asserted-by":"crossref","first-page":"E626","DOI":"10.1152\/ajpendo.2001.281.3.E626","article-title":"Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?","volume":"281","author":"Mamo","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cjca.2010.12.020_bib11","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/01.ATV.19.10.2474","article-title":"Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins","volume":"19","author":"Cohn","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2010.12.020_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/clinchem\/48.2.278","article-title":"Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity","volume":"48","author":"Chan","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-9150(99)00275-0","article-title":"Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes","volume":"148","author":"Phillips","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.020_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacl.2009.02.006","article-title":"Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity","volume":"3","author":"Su","year":"2009","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.cjca.2010.12.020_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0005-2760(94)90266-6","article-title":"Effects of triacylglycerol-saturated acyl chains on the clearance of chylomicron-like emulsions from the plasma of the rat","volume":"1211","author":"Mortimer","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cjca.2010.12.020_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0005-2760(92)90202-7","article-title":"Plasma clearance of model lipoproteins containing saturated and polyunsaturated monoacylglycerols injected intravenously in the rat","volume":"1127","author":"Mortimer","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cjca.2010.12.020_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosissup.2008.05.002","article-title":"Chylomicrons in disease: future challenges invited keynote address","volume":"9","author":"Redgrave","year":"2008","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.cjca.2010.12.020_bib18","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1016\/S0021-9258(18)60687-8","article-title":"The effect of triacyl-sn-glycerol structure on the metabolism of chylomicrons and triacylglycerol-rich emulsions in the rat","volume":"263","author":"Redgrave","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jn\/136.4.971","article-title":"High cholesterol intake modifies chylomicron metabolism in normolipidemic young men","volume":"136","author":"Cesar","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.cjca.2010.12.020_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jn\/132.2.176","article-title":"Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test","volume":"132","author":"Martins","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.cjca.2010.12.020_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-1681.1991.tb01424.x","article-title":"Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoproteins from plasma: studies with chylomicron-like lipid emulsions in rats","volume":"18","author":"Mackintosh","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cjca.2010.12.020_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1440-1681.1991.tb01396.x","article-title":"Effects of adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats","volume":"18","author":"Mackintosh","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cjca.2010.12.020_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00005344-199603000-00019","article-title":"Vasoactive mediators affect the clearance of lipids from emulsion models of plasma lipoproteins in rats","volume":"27","author":"Mackintosh","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cjca.2010.12.020_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cca.2007.09.022","article-title":"Remnant lipoprotein metabolism is improved more when body weight is reduced by exercise than by dietary restriction","volume":"388","author":"Yamada","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cjca.2010.12.020_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1242\/jcs.02803","article-title":"Vesicle-associated membrane protein 7 is expressed in intestinal ER","volume":"119","author":"Siddiqi","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cjca.2010.12.020_bib26","doi-asserted-by":"crossref","first-page":"20974","DOI":"10.1074\/jbc.M601401200","article-title":"The identification of a novel endoplasmic reticulum to golgi SNARE complex used by the prechylomicron transport vesicle","volume":"281","author":"Siddiqi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib27","series-title":"Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism","first-page":"181","article-title":"The isolation and quantitative analysis of serum lipoproteins","author":"Lindgren","year":"1972"},{"key":"10.1016\/j.cjca.2010.12.020_bib28","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1172\/JCI106203","article-title":"Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption","volume":"48","author":"Ockner","year":"1969","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjca.2010.12.020_bib29","first-page":"435","article-title":"Lipoproteins associated with the golgi apparatus isolated from epithelial cells of rat small intestine","volume":"25","author":"Mahley","year":"1971","journal-title":"Lab Invest"},{"key":"10.1016\/j.cjca.2010.12.020_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ajcn\/63.6.911","article-title":"Oral fat exposure alters postprandial lipid metabolism in humans","volume":"63","author":"Mattes","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cjca.2010.12.020_bib31","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1093\/jn\/132.12.3656","article-title":"Oral fat exposure increases the first phase triacylglycerol concentration due to release of stored lipid in humans","volume":"132","author":"Mattes","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.cjca.2010.12.020_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00394-004-0538-3","article-title":"Meal ingestion provokes entry of lipoproteins containing fat from the previous meal: possible metabolic implications","volume":"44","author":"Silva","year":"2005","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.cjca.2010.12.020_bib33","first-page":"G599","article-title":"Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine","volume":"247","author":"Tso","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2010.12.020_bib34","doi-asserted-by":"crossref","first-page":"19565","DOI":"10.1074\/jbc.274.28.19565","article-title":"Assembly and secretion of chylomicrons by differentiated caco-2 cells: nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly","volume":"274","author":"Luchoomun","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib35","first-page":"G715","article-title":"Formation and transport of chylomicrons by enterocytes to the lymphatics","volume":"250","author":"Tso","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2010.12.020_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/17425247.4.3.275","article-title":"Progress in absorption enhancers based on tight junction","volume":"4","author":"Kondoh","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cjca.2010.12.020_bib37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.mehy.2003.10.037","article-title":"Do surface-active lipids in food increase the intestinal permeability to toxic substances and allergenic agents?","volume":"63","author":"Llback","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cjca.2010.12.020_bib38","first-page":"G384","article-title":"Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion","volume":"261","author":"Kvietys","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2010.12.020_bib39","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1073\/pnas.77.5.2465","article-title":"Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons","volume":"77","author":"Kane","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2010.12.020_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(99)00397-4","article-title":"A proposed model for the assembly of chylomicrons","volume":"148","author":"Hussain","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.020_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0007114598001263","article-title":"The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein","volume":"80","author":"White","year":"1998","journal-title":"Br J Nutr"},{"key":"10.1016\/j.cjca.2010.12.020_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2005.08.020","article-title":"Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition","volume":"187","author":"Phillips","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.020_bib43","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s001250051252","article-title":"The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes","volume":"42","author":"Gleeson","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2010.12.020_bib44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-9150(01)00721-3","article-title":"Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?","volume":"160","author":"Phillips","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.020_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/meta.2002.33350","article-title":"Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes","volume":"51","author":"Phillips","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.cjca.2010.12.020_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/en.2004-1143","article-title":"Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed syrian golden hamster","volume":"146","author":"Lewis","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cjca.2010.12.020_bib47","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/ajpendo.90899.2008","article-title":"Intestinal lipid absorption","volume":"296","author":"Iqbal","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cjca.2010.12.020_bib48","doi-asserted-by":"crossref","first-page":"31610","DOI":"10.1074\/jbc.M301177200","article-title":"Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells","volume":"278","author":"Iqbal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI108963","article-title":"Rat intestine secretes discoid high density lipoprotein","volume":"61","author":"Green","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjca.2010.12.020_bib50","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI27352","article-title":"Intestinal ABCA1 directly contributes to HDL biogenesis in vivo","volume":"116","author":"Brunham","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjca.2010.12.020_bib51","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1194\/jlr.M500023-JLR200","article-title":"Evidence for multiple complementary pathways for efficient cholesterol absorption in mice","volume":"46","author":"Iqbal","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cjca.2010.12.020_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cmet.2008.03.005","article-title":"IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA","volume":"7","author":"Iqbal","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.cjca.2010.12.020_bib53","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(02)08351-4","article-title":"Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: The LIPID trial follow-up","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2010.12.020_bib54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2010.12.020_bib55","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(01)06200-6","article-title":"Blood lipid concentrations and risk of myocardial infarction","volume":"358","author":"Mediene-Benchekor","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2010.12.020_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00041433-200302000-00004","article-title":"Dietary fat, fatty acid composition in plasma and the metabolic syndrome","volume":"14","author":"Vessby","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2010.12.020_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archinte.163.1.33","article-title":"Cardiovascular disease in type 2 diabetes mellitus: current management guidelines","volume":"163","author":"Mooradian","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2010.12.020_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00019501-199408000-00008","article-title":"Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin","volume":"5","author":"Mamo","year":"1994","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.cjca.2010.12.020_bib59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(99)00341-X","article-title":"Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats","volume":"149","author":"Proctor","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.020_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BST0350477","article-title":"Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome","volume":"35","author":"Mangat","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.cjca.2010.12.020_bib61","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.atherosclerosis.2006.03.013","article-title":"Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome","volume":"190","author":"Vine","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.020_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosissup.2008.05.004","article-title":"Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome","volume":"9","author":"Vine","year":"2008","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.cjca.2010.12.020_bib63","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2337\/diabetes.50.2.462","article-title":"Acute hyperinsulinism modulates plasma apolipoprotein B-48 triglyceride-rich lipoproteins in healthy subjects during the postprandial period","volume":"50","author":"Harbis","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2010.12.020_bib64","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/db04-1084","volume":"55","author":"Federico","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2010.12.020_bib65","doi-asserted-by":"crossref","first-page":"31646","DOI":"10.1074\/jbc.M200544200","volume":"277","author":"Haidari","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib66","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jprot.2010.01.010","article-title":"Proteomic profiling of intestinal prechylomicron transport vesicle (PCTV)-associated proteins in an animal model of insulin resistance","volume":"3","author":"Wong","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.cjca.2010.12.020_bib67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/db06-0518","article-title":"Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins","volume":"56","author":"Qin","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2010.12.020_bib68","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11892-006-0034-7","article-title":"Incretins and the development of type 2 diabetes","volume":"6","author":"Meier","year":"2006","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.cjca.2010.12.020_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.cjca.2010.12.020_bib70","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00125-005-0126-y","article-title":"Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans","volume":"49","author":"Meier","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2010.12.020_bib71","doi-asserted-by":"crossref","first-page":"G943","DOI":"10.1152\/ajpgi.00303.2004","article-title":"GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats","volume":"288","author":"Qin","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cjca.2010.12.020_bib72","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00125-009-1611-5","article-title":"The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice","volume":"53","author":"Hsieh","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2010.12.020_bib73","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3945\/ajcn.2008.26720","article-title":"Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver","volume":"89","author":"Musso","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cjca.2010.12.020_bib74","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2010.12.020_bib75","first-page":"E815","article-title":"Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats","volume":"273","author":"Fischer","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2010.12.020_bib76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2005.10.004","article-title":"Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans","volume":"130","author":"Meier","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cjca.2010.12.020_bib77","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.gastro.2009.05.051","article-title":"Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production is mediated via CD36","volume":"137","author":"Hsieh","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cjca.2010.12.020_bib78","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/gut.47.2.178","article-title":"Leptin secretion and leptin receptor in the human stomach","volume":"47","author":"Sobhani","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cjca.2010.12.020_bib79","doi-asserted-by":"crossref","first-page":"26194","DOI":"10.1074\/jbc.273.40.26194","article-title":"Leptin action in intestinal cells","volume":"273","author":"Morton","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib80","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1074\/jbc.M502501200","article-title":"Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size","volume":"281","author":"Lu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2010.12.020_bib81","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1194\/jlr.M005744","article-title":"An intrinsic gut leptin melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption","volume":"51","author":"Iqbal","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cjca.2010.12.020_bib82","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.020_bib83","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ncpcardio1250","article-title":"Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia","volume":"5","author":"Samaha","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.cjca.2010.12.020_bib84","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1194\/jlr.M300094-JLR200","article-title":"CP-346086: an MTP inhibitor that lowers plasma total, VLDL, and LDL cholesterol and triglycerides by up to 70% in experimental animals and in humans","volume":"44","author":"Chandler","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cjca.2010.12.020_bib85","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3748\/wjg.15.2987","article-title":"Pluronic L-81 ameliorates diabetic symptoms in db\/db mice through transcriptional regulation of microsomal triglyceride transfer protein","volume":"15","author":"Au","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cjca.2010.12.020_bib86","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00228-008-0462-1","article-title":"Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia","volume":"64","author":"Vissers","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2010.12.020_bib87","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00125-006-0340-2","article-title":"Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes","volume":"49","author":"Matikainen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2010.12.020_bib88","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2337\/dc09-1914","article-title":"DURATION-1: Exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks","volume":"33","author":"Buse","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2010.12.020_bib89","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.2337\/dc09-2361","article-title":"Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition","volume":"33","author":"Bunck","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2010.12.020_bib90","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/ATVBAHA.109.195693","article-title":"Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo","volume":"30","author":"Yasuda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2010.12.020_bib91","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jama.301.11.1131","article-title":"ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial","volume":"301","author":"Meuwese","year":"2009","journal-title":"JAMA"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1000036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1000036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:35:53Z","timestamp":1760106953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X1000036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0828282X1000036X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2010.12.020","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2010.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}